178 related articles for article (PubMed ID: 7654731)
21. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
22. Effect of bezafibrate and colestyramine in patients with primary hypercholesterolemia.
Steinhagen-Thiessen E; Müller S; Holler HD; Lang PD
Arzneimittelforschung; 1987 Jun; 37(6):726-8. PubMed ID: 3311054
[TBL] [Abstract][Full Text] [Related]
23. Effect of fluvastatin or bezafibrate on the distribution of high density lipoprotein subpopulations in patients with familial hypercholesterolemia.
Hailer S; Pogarell O; Keller C; Wolfram G
Arzneimittelforschung; 1996 Sep; 46(9):879-83. PubMed ID: 8876936
[TBL] [Abstract][Full Text] [Related]
24. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
[TBL] [Abstract][Full Text] [Related]
25. Fluvastatin in combination with other lipid-lowering agents.
Jokubaitis LA
Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
[TBL] [Abstract][Full Text] [Related]
26. Fluvastatin in combination with other lipid-lowering agents.
Jokubaitis LA
Br J Clin Pract Suppl; 1996 Jan; 77A():28-32. PubMed ID: 8729588
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of lovastatin in hypercholesterolemic women.
D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
Clin Ther; 1992; 14(3):390-5. PubMed ID: 1638580
[TBL] [Abstract][Full Text] [Related]
28. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
[TBL] [Abstract][Full Text] [Related]
29. Impact of fluvastatin on hyperlipidemia after renal transplantation.
Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
[TBL] [Abstract][Full Text] [Related]
30. Atherogenic risk reduction in patients with dyslipidaemia. comparison between bezafibrate and lovastatin.
Sinzinger H; Pirich C; Kondor P; Etti H
Eur Heart J; 1995 Nov; 16(11):1491-501. PubMed ID: 8881840
[TBL] [Abstract][Full Text] [Related]
31. Continued benefit of lovastatin in the treatment of hypercholesterolemia in 36 patients.
Wallace MB; Warren SG; Bates MC; Robinson PA
W V Med J; 1995 Feb; 91(2):50-3. PubMed ID: 7610642
[TBL] [Abstract][Full Text] [Related]
32. Low-dose lovastatin safely lowers cholesterol after cardiac transplantation.
Kobashigawa JA; Murphy FL; Stevenson LW; Moriguchi JD; Kawata N; Kamjoo P; Brownfield E; Wilmarth J; Leonard L; Chuck C
Circulation; 1990 Nov; 82(5 Suppl):IV281-3. PubMed ID: 2225417
[TBL] [Abstract][Full Text] [Related]
33. Effect of bezafibrate on low levels of high density lipoprotein cholesterol in normolipidemia. Study in coronary patients and their first degree relatives.
Neuman J; Neuman MP; Di Biase L
Arzneimittelforschung; 1986 Nov; 36(11):1690-3. PubMed ID: 3814229
[TBL] [Abstract][Full Text] [Related]
34. Dual bezafibrate-simvastatin therapy for combined hyperlipidaemia.
Hutchesson AC; Moran A; Jones AF
J Clin Pharm Ther; 1994 Dec; 19(6):387-9. PubMed ID: 7876371
[TBL] [Abstract][Full Text] [Related]
35. Comparison of bezafibrate versus lovastatin for lowering plasma insulin, fibrinogen, and plasminogen activator inhibitor-1 concentrations in hyperlipemic heart transplant patients.
Zambrana JL; Velasco F; Castro P; Concha M; Vallés F; Montilla P; Jimenéz-Perepérez JA; López-Miranda J; Pérez-Jiménez F
Am J Cardiol; 1997 Oct; 80(7):836-40. PubMed ID: 9381994
[TBL] [Abstract][Full Text] [Related]
36. Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins.
Nakandakare E; Garcia RC; Rocha JC; Sperotto G; Oliveira HC; Quintão EC
Atherosclerosis; 1990 Dec; 85(2-3):211-7. PubMed ID: 2102085
[TBL] [Abstract][Full Text] [Related]
37. A crossover comparison of the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemic organ transplant recipients.
Hanes DS; Nicholson PG; Raval DD; Hooper FL; Behrens MT; Weir MR
Am J Ther; 1997; 4(2-3):85-91. PubMed ID: 10423597
[TBL] [Abstract][Full Text] [Related]
38. Dyslipoproteinemias after heart and heart-lung transplantation: potential relation to accelerated graft arteriosclerosis.
Bilodeau M; Fitchett DH; Guerraty A; Sniderman AD
J Heart Transplant; 1989; 8(6):454-9. PubMed ID: 2614546
[TBL] [Abstract][Full Text] [Related]
39. Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A.
Traindl O; Reading S; Franz M; Falger S; Klauser R; Gisinger J; Widhalm K; Kovarik J
Transplant Proc; 1992 Dec; 24(6):2745-7. PubMed ID: 1465924
[No Abstract] [Full Text] [Related]
40. Improvement of hyperlipidaemia by bezafibrate treatment in RDT patients.
Grützmacher P; Scheuermann E; Lang W
Proc Eur Dial Transplant Assoc; 1981; 18():169-75. PubMed ID: 7036147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
